CNBX PharmaceuticalsCNBX
13F holders, Q2 2024 (June 30)3holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding CNBX Pharmaceuticals Inc. (CNBX) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Private Ocean, LLC ($0), Archer Investment Corp ($0) and RFP Financial Group LLC ($0).
- Company
- CNBX Pharmaceuticals Inc.
- CUSIP
- 13764M209
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 9 shares bought, net +9 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Private Ocean, LLC | 0.00% | New | 9 | $0 |
| Archer Investment Corp | 0.00% | No change | 9 | $0 |
| RFP Financial Group LLC | 0.00% | No change | 15 | $0 |
"% of holder's portfolio" is CNBX's weight in each manager's 13F, not the share of CNBX Pharmaceuticals Inc. the manager owns.